QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=F1403CB081C8143DBB2D100681C40D7E;jsessionid=3FEA0194700ADC6F83011A89011D8DAD;jsessionid=95C5D34FBC008D36D8967773D8C25903;jsessionid=D853A55CA208A9DB907C6187FAB048BB (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
3. Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longi…
4. ATXN2 is a target of N-terminal proteolysis.
5. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=F1403CB081C8143DBB2D100681C40D7E;jsessionid=3FEA0194700ADC6F83011A89011D8DAD;jsessionid=95C5D34FBC008D36D8967773D8C25903;jsessionid=D853A55CA208A9DB907C6187FAB048BB